Skip to content
10-Q

Quarterly Report

MICROLIN BIO, INC

0001393905-15-000615

← back to feed
Filed
Nov 16, 2015 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2015 · Sep 30, 2015 9.1M sh
Operating Cash Flow Q3 2015 · Sep 30, 2015 −$19.03K
Operating Cash Flow Q3 2015 · Sep 30, 2014 −$28.08K
Cash And Equivalents Q3 2015 · Sep 30, 2015 $97
Cash And Equivalents Q3 2015 · Dec 31, 2014 $1.94K
Cash And Equivalents Q3 2015 · Sep 30, 2014 $379
Cash And Equivalents Q3 2015 · Dec 31, 2013 $7.48K
Stockholders Equity Q3 2015 · Sep 30, 2015 −$55.86K
Stockholders Equity Q3 2015 · Dec 31, 2014 −$39.96K
Current Liabilities Q3 2015 · Sep 30, 2015 $55.96K
Current Liabilities Q3 2015 · Dec 31, 2014 $43.1K
Total Liabilities Q3 2015 · Sep 30, 2015 $55.96K
Total Liabilities Q3 2015 · Dec 31, 2014 $43.1K
Current Assets Q3 2015 · Sep 30, 2015 $97
Current Assets Q3 2015 · Dec 31, 2014 $3.14K
Total Assets Q3 2015 · Sep 30, 2015 $97
Total Assets Q3 2015 · Dec 31, 2014 $3.14K
Sga Expense Q3 2015 · Sep 30, 2015 $370
Sga Expense Q3 2015 · Sep 30, 2015 $885
Sga Expense Q3 2015 · Sep 30, 2014 $3.24K
Sga Expense Q3 2015 · Sep 30, 2014 $4.69K
Net Income Q3 2015 · Sep 30, 2015 −$9.66K
Net Income Q3 2015 · Sep 30, 2015 −$24.5K
Net Income Q3 2015 · Sep 30, 2014 −$40.99K
Net Income Q3 2015 · Sep 30, 2014 −$128.9K
Revenue Q3 2015 · Sep 30, 2015 $1.8K